St. Louis University to Run Clinical Study on Rasagiline/Dopamine Agonist Combo

Researchers at St. Louis University are gearing up for a clinical study to see whether the combination of rasagiline and a dopamine agonist is safe and effective in PD patients. The trial is currently looking for participants. Read the St. Louis Post-Dispatch article for details.